Fulvestrant is used in the management and treatment of advanced breast cancer. It is a selective estrogen receptor degrader. This activity outlines the indications, action, and contraindications for fulvestrant as a valuable agent in the treatment of advanced breast carcinoma.

**Objectives:**
- Identify the mechanism of action of fulvestrant. 
- Describe the possible adverse effects that may accompany therapy with fulvestrant. 
- Summarize the clinical benefit of fulvestrant in the treatment of breast cancer. 
- Explain the importance of collaboration and communication amongst the interprofessional team to ensure the appropriate selection of candidates for fulvestrant trials and improve patient outcomes.